136 related articles for article (PubMed ID: 35124372)
1. TOPBP1 regulates resistance of gastric cancer to oxaliplatin by promoting transcription of PARP1.
Fang Z; Gong C; Ye Z; Wang W; Zhu M; Hu Y; Liu Z; Zhou W; Li H
DNA Repair (Amst); 2022 Mar; 111():103278. PubMed ID: 35124372
[TBL] [Abstract][Full Text] [Related]
2. METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability.
Li H; Wang C; Lan L; Yan L; Li W; Evans I; Ruiz EJ; Su Q; Zhao G; Wu W; Zhang H; Zhou Z; Hu Z; Chen W; Oliveira JM; Behrens A; Reis RL; Zhang C
Cell Mol Life Sci; 2022 Feb; 79(3):135. PubMed ID: 35179655
[TBL] [Abstract][Full Text] [Related]
3. The DNA topoisomerase IIbeta binding protein 1 (TopBP1) interacts with poly (ADP-ribose) polymerase (PARP-1).
Wollmann Y; Schmidt U; Wieland GD; Zipfel PF; Saluz HP; Hänel F
J Cell Biochem; 2007 Sep; 102(1):171-82. PubMed ID: 17340632
[TBL] [Abstract][Full Text] [Related]
4. A small-molecule inhibitor of TopBP1 exerts anti-MYC activity and synergy with PARP inhibitors.
Lin FT; Liu K; Garan LAW; Folly-Kossi H; Song Y; Lin SJ; Lin WC
Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2307793120. PubMed ID: 37878724
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of CRABP2 by TET1-mediated DNA hydroxymethylation attenuates mitochondrial apoptosis and promotes oxaliplatin resistance in gastric cancer.
Tang X; Liang Y; Sun G; He Q; Hou Z; Jiang X; Gao P; Qu H
Cell Death Dis; 2022 Oct; 13(10):848. PubMed ID: 36195596
[TBL] [Abstract][Full Text] [Related]
6. PARP1: A potential biomarker for gastric cancer.
Afzal H; Yousaf S; Rahman F; Ahmed MW; Akram Z; Akhtar Kayani M; Mahjabeen I
Pathol Res Pract; 2019 Aug; 215(8):152472. PubMed ID: 31174925
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-31-5p regulates chemosensitivity by preventing the nuclear location of PARP1 in hepatocellular carcinoma.
Que KT; Zhou Y; You Y; Zhang Z; Zhao XP; Gong JP; Liu ZJ
J Exp Clin Cancer Res; 2018 Nov; 37(1):268. PubMed ID: 30400960
[TBL] [Abstract][Full Text] [Related]
8. TOPBP1 regulates RAD51 phosphorylation and chromatin loading and determines PARP inhibitor sensitivity.
Moudry P; Watanabe K; Wolanin KM; Bartkova J; Wassing IE; Watanabe S; Strauss R; Troelsgaard Pedersen R; Oestergaard VH; Lisby M; Andújar-Sánchez M; Maya-Mendoza A; Esashi F; Lukas J; Bartek J
J Cell Biol; 2016 Feb; 212(3):281-8. PubMed ID: 26811421
[TBL] [Abstract][Full Text] [Related]
9. TopBP1 promotes malignant progression and correlates with poor prognosis in osteosarcoma.
Wu DP; Yan XB; Liu LG; Tian C; Han K; Zhang H; Min DL
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4022-4031. PubMed ID: 29028101
[TBL] [Abstract][Full Text] [Related]
10. PAK6 promotes homologous-recombination to enhance chemoresistance to oxaliplatin through ATR/CHK1 signaling in gastric cancer.
Huang W; Han Z; Sun Z; Feng H; Zhao L; Yuan Q; Chen C; Yu S; Hu Y; Yu J; Liu H; Li G; Jiang Y
Cell Death Dis; 2022 Jul; 13(7):658. PubMed ID: 35902562
[TBL] [Abstract][Full Text] [Related]
11. Verapamil enhances the sensitivity of oxaliplatin to tumor cells by influencing the PARP pathway.
Zhang T; Yang G; Liu Y; Fan P
Pharmazie; 2019 Dec; 74(12):740-743. PubMed ID: 31907114
[TBL] [Abstract][Full Text] [Related]
12. ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance.
Lin L; Li X; Pan C; Lin W; Shao R; Liu Y; Zhang J; Luo Y; Qian K; Shi M; Bin J; Liao Y; Liao W
Cell Death Dis; 2019 Feb; 10(3):173. PubMed ID: 30787271
[TBL] [Abstract][Full Text] [Related]
13. Lymph node metastasis of gastric cancer is associated with the interaction between poly (ADP-ribose) polymerase 1 and matrix metallopeptidase 2.
Kim J; Pyun JA; Cho SW; Lee K; Kwack K
DNA Cell Biol; 2011 Dec; 30(12):1011-7. PubMed ID: 21612407
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of PARP1 activity enhances chemotherapeutic efficiency in cisplatin-resistant gastric cancer cells.
Wang Q; Xiong J; Qiu D; Zhao X; Yan D; Xu W; Wang Z; Chen Q; Panday S; Li A; Wang S; Zhou J
Int J Biochem Cell Biol; 2017 Nov; 92():164-172. PubMed ID: 28827033
[TBL] [Abstract][Full Text] [Related]
15. Modulation of YBX1-mediated PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to oxaliplatin in gastric cancer.
Lin C; Lin P; Yao H; Liu S; Lin X; He R; Teng Z; Zuo X; Li Y; Ye J; Zhu G
Cancer Lett; 2024 Apr; 587():216712. PubMed ID: 38364962
[TBL] [Abstract][Full Text] [Related]
16. Insights from the crystal structure of the sixth BRCT domain of topoisomerase IIbeta binding protein 1.
Leung CC; Kellogg E; Kuhnert A; Hänel F; Baker D; Glover JN
Protein Sci; 2010 Jan; 19(1):162-7. PubMed ID: 19937654
[TBL] [Abstract][Full Text] [Related]
17. MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.
Tentori L; Muzi A; Dorio AS; Dolci S; Campolo F; Vernole P; Lacal PM; Praz F; Graziani G
Cancer Chemother Pharmacol; 2013 Jul; 72(1):117-25. PubMed ID: 23636450
[TBL] [Abstract][Full Text] [Related]
18. TopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53.
Lv Y; Huo Y; Yu X; Liu R; Zhang S; Zheng X; Zhang X
Drug Des Devel Ther; 2016; 10():3053-3064. PubMed ID: 27729767
[TBL] [Abstract][Full Text] [Related]
19. HPF1 dynamically controls the PARP1/2 balance between initiating and elongating ADP-ribose modifications.
Langelier MF; Billur R; Sverzhinsky A; Black BE; Pascal JM
Nat Commun; 2021 Nov; 12(1):6675. PubMed ID: 34795260
[TBL] [Abstract][Full Text] [Related]
20. Stat1 confers sensitivity to radiation in cervical cancer cells by controlling Parp1 levels: a new perspective for Parp1 inhibition.
Raspaglio G; Buttarelli M; Filippetti F; Battaglia A; Buzzonetti A; Scambia G; Gallo D
Cell Death Dis; 2021 Oct; 12(10):933. PubMed ID: 34642300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
